Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.2.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.2.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.45ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.45NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GP.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GP.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GP.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GP.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.4.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBQORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.62ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.62NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.80 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.80 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.80 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.80 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.43.8 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.43.8 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-1427.97China
AY.43.8 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
AY.43.8 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.128 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.128 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.128 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.128 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.220ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.220ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.220ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.220NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.58ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.58NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used